MiddleBrook Pharmaceuticals Inc (MBRKQ1)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
20425 SENECA MEADOWS PARKWAY GERMANTOWN, MD 20878

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Focuses on developing and commercializing pulsatile drug products for the treatment of infectious disease. As of Dec. 31, 2004, the company's lead PULSYS product candidates were in two separate Phase III trials and it had four additional pulsatile product candidates in preclinical development.

View SEC Filings from MBRKQ1 instead.

View recent insider trading info

Funds Holding MBRKQ1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MBRKQ1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COLE BRAD SVP, GC

  • Officer
100 2010-12-06 0

EGI-MBRK, L.L.C.

EGI-FUND (08-10) INVESTORS, L.L.C.

SZ INVESTMENTS LLC

CHAI TRUST CO LLC

  • 10% Owner
19,022,726 2010-11-22 0

BLYTH LORD JAMES

  • Director
  • CONSULTANT
0 2009-11-24 0

CAVANAUGH JAMES H

  • Director
  • 10% Owner
0 2009-06-23 0

WERNER HAROLD R

  • Director
  • 10% Owner
0 2009-06-23 0

PATE WILLIAM

  • Director
0 2009-06-23 0

DOUGLAS R GORDON

  • Director
0 2009-06-23 0

VOGELBAUM MARTIN

  • Director
0 2009-06-23 0

DUGAN RICHARD W

  • Director
0 2009-06-23 0

SOTIR MARK R

  • Director
0 2009-06-23 0

MILLER TIMOTHY L SVP, SALES OPS & ADMIN

  • Officer
22,500 2009-03-12 0

KOOS FRANK SVP, SALES & BUSINESS DEVELOP

  • Officer
0 2008-11-28 0

BURNSIDE BETH A SVP, REG AFFAIRS, COMP & STRAT

  • Officer
0 2008-09-10 0

TREACY DONALD J SVP, DEVEL & MANF OPER

  • Officer
0 2008-09-10 0

CLAUSEN SUSAN P SVP, CLINICAL RES & MED AFF

  • Officer
0 2008-09-10 0

THIEVON JOHN PRESIDENT AND CEO

  • Officer
  • Director
133,200 2008-09-05 0

BECKER DAVID PAUL EVP & CFO

  • Officer
133,200 2008-09-05 0

HOCKMEYER WAYNE T

  • Director
0 2008-06-04 0

RUDNIC EDWARD M PRESIDENT AND CEO

  • Officer
  • Director
0 2008-02-13 0

LOW ROBERT C VICE PRESIDENT & CFO

  • Officer
0 2008-02-13 0

RHO VENTURES V, L.P.

RHO VENTURES V AFFILIATES, LLC

RMV V, L.L.C.

RHO CAPITAL PARTNERS LLC

RHO INVESTMENT PARTNERS Q-4 L.P.

RUCH JOSHUA

KAIROUZ HABIB

RHO MANAGEMENT PARTNERS L P

ATLAS CAPITAL CORP

LESCHLY MARK

  • 10% Owner
5,352,478 2007-04-12 0

HEALTHCARE VENTURES VI LP

HEALTHCARE PARTNERS VI LP

CAVANAUGH JAMES H

CROUSE WILLIAM W

LITTLECHILD JOHN W

WERNER HAROLD R

MIRABELLI CHRISTOPHER

LAWLOR AUGUSTINE

AGUIAR ERIC

  • Director
  • 10% Owner
6,727,566 2007-04-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments